1Division of Hematology.
2College of Pharmacy.
J Natl Compr Canc Netw. 2021 Mar 26;19(9):1027-1036. doi: 10.6004/jnccn.2020.7686.
Gauging fitness remains a challenge among older adults with hematologic malignancies, and interventions to restore function are lacking. We pilot a structured exercise intervention and novel biologic correlates of aging using epigenetic clocks and markers of immunosenescence to evaluate changes in function and clinical outcomes.
Older adults (n=30) with hematologic malignancy actively receiving treatment were screened and enrolled in a 6-month exercise intervention, the Otago Exercise Programme (OEP). The impact of the OEP on geriatric assessment metrics and health-related quality of life were captured. Clinical outcomes of overall survival and hospital utilization (inpatient length of stay and emergency department use) in relationship to geriatric deficits were analyzed.
Older adults (median age, 75.5 years [range, 62-83 years]) actively receiving treatment were enrolled in the OEP. Instrumental activities of daily living and physical health scores (PHS) increased significantly with the OEP intervention (median PHS: visit 1, 55 [range, 0-100]; visit 2, 70 [range, 30-100]; P<.01). Patient-reported Karnofsky performance status increased significantly, and the improvement was sustained (median [range]: visit 1, 80 [40-100]; visit 3, 90 [50-100]; P=.05). Quality of life (Patient-Reported Outcome Measurement Information System [PROMIS]) improved significantly by the end of the 6-month period (median [range]: visit 1, 32.4 [19.9-47.7]; visit 3, 36.2 [19.9-47.7]; P=.01]. Enhanced measures of gait speed and balance, using the Short Physical Performance Battery scores, were associated with a 20% decrease in risk of death (hazard ratio, 0.80; 95% CI, 0.65-0.97; P=.03) and a shorter hospital length of stay (decrease of 1.29 days; 95% CI, -2.46 to -0.13; P=.03). Peripheral blood immunosenescent markers were analyzed in relationship to clinical frailty and reports of mPhenoAge epigenetic analysis are preliminarily reported. Chronologic age had no relationship to overall survival, length of stay, or emergency department utilization.
The OEP was effective in improving quality of life, and geriatric tools predicted survival and hospital utilization among older adults with hematologic malignancies.
评估老年人的健康状况仍然是血液系统恶性肿瘤患者面临的一项挑战,目前缺乏恢复功能的干预措施。我们采用一种结构化的运动干预方法和新型衰老的生物学相关性指标,使用表观遗传时钟和免疫衰老标志物来评估功能变化和临床结局。
筛选并招募了 30 名正在接受治疗的血液系统恶性肿瘤老年患者参与一项为期 6 个月的运动干预计划,即奥塔哥运动计划(OEP)。研究中评估了 OEP 对老年综合评估指标和健康相关生活质量的影响。分析了与老年缺陷相关的总生存率和医院利用(住院时间和急诊部门使用)的临床结果。
研究招募了正在接受治疗的老年患者(中位年龄 75.5 岁[范围 62-83 岁])参与 OEP。OEP 干预后,日常生活活动能力和身体健康评分(PHS)显著提高(PHS 中位数:访视 1,55[范围 0-100];访视 2,70[范围 30-100];P<.01)。患者报告的卡诺夫斯基表现状态显著提高,且改善持续存在(中位数[范围]:访视 1,80[40-100];访视 3,90[50-100];P=.05)。6 个月后,生活质量(患者报告的结局测量信息系统[PROMIS])显著改善(中位数[范围]:访视 1,32.4[19.9-47.7];访视 3,36.2[19.9-47.7];P=.01)。使用简短体能表现电池评分增强的步态速度和平衡测量与死亡风险降低 20%相关(风险比,0.80;95%置信区间,0.65-0.97;P=.03),且住院时间缩短 1.29 天(95%置信区间,-2.46 至-0.13;P=.03)。分析了外周血免疫衰老标志物与临床虚弱的关系,并初步报告了 mPhenoAge 表观遗传分析的报告。生物学年龄与总生存率、住院时间或急诊部门使用率无关。
OEP 可有效提高生活质量,老年综合评估工具可预测血液系统恶性肿瘤老年患者的生存率和医院利用情况。